ArticleCPT: pharmacometrics & systems pharmacology2026
Development of the Weight-Tiered Q3W Regimen of Amivantamab in Combination With Carboplatin-Pemetrexed in EGFR-Mutated Non-Small Cell Lung Cancer.
Dongfen Yuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.